BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11106643)

  • 41. Intracellular trafficking/membrane targeting of human reduced folate carrier expressed in Xenopus oocytes.
    Subramanian VS; Marchant JS; Parker I; Said HM
    Am J Physiol Gastrointest Liver Physiol; 2001 Dec; 281(6):G1477-86. PubMed ID: 11705753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells.
    Wong SC; Zhang L; Proefke SA; Hukku B; Matherly LH
    Biochem Pharmacol; 1998 Apr; 55(7):1135-8. PubMed ID: 9605439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Despite some expression of folate receptor alpha in human mesothelioma cells, internalization of methotrexate is predominantly carrier mediated.
    Khokhar NZ; Lam AF; Rusch VW; Sirotnak FM
    J Thorac Cardiovasc Surg; 2002 May; 123(5):862-8. PubMed ID: 12019370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a human alternatively spliced truncated reduced folate carrier increasing folate accumulation in parental leukemia cells.
    Drori S; Sprecher H; Shemer G; Jansen G; Goldman ID; Assaraf YG
    Eur J Biochem; 2000 Feb; 267(3):690-702. PubMed ID: 10651805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transmembrane domains 4, 5, 7, 8, and 10 of the human reduced folate carrier are important structural or functional components of the transmembrane channel for folate substrates.
    Hou Z; Ye J; Haska CL; Matherly LH
    J Biol Chem; 2006 Nov; 281(44):33588-96. PubMed ID: 16923800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells.
    Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ
    Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of human reduced folate carrier in fetal Down syndrome brain.
    Lubec G; Bajo M; Cheon MS; Bajova H; Matherly LH
    J Neural Transm Suppl; 2003; (67):95-103. PubMed ID: 15068242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
    Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
    Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
    Ma D; Huang H; Moscow JA
    Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.
    Rothem L; Ifergan I; Kaufman Y; Priest DG; Jansen G; Assaraf YG
    Biochem J; 2002 Nov; 367(Pt 3):741-50. PubMed ID: 12139489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of the loss of capacity for N-glycosylation on the transport activity and cellular localization of the human reduced folate carrier.
    Wong SC; Zhang L; Proefke SA; Matherly LH
    Biochim Biophys Acta; 1998 Oct; 1375(1-2):6-12. PubMed ID: 9767079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The tumour suppressor protein p53 can repress transcription of cyclin B.
    Krause K; Wasner M; Reinhard W; Haugwitz U; Dohna CL; Mössner J; Engeland K
    Nucleic Acids Res; 2000 Nov; 28(22):4410-8. PubMed ID: 11071927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance.
    Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG
    J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.
    Henderson GB; Stein CA
    Nucleic Acids Res; 1995 Sep; 23(18):3726-31. PubMed ID: 7479003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
    Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
    Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure and regulation of the murine reduced folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates.
    Liu M; Ge Y; Cabelof DC; Aboukameel A; Heydari AR; Mohammad R; Matherly LH
    J Biol Chem; 2005 Feb; 280(7):5588-97. PubMed ID: 15579899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells.
    Lee SJ; Ha MJ; Lee J; Nguyen P; Choi YH; Pirnia F; Kang WK; Wang XF; Kim SJ; Trepel JB
    J Biol Chem; 1998 Apr; 273(17):10618-23. PubMed ID: 9553123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression.
    Schwartzenberg-Bar-Yoseph F; Armoni M; Karnieli E
    Cancer Res; 2004 Apr; 64(7):2627-33. PubMed ID: 15059920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.